GAO Slams FDA For Lax Monitoring Of Foreign Drugs
The U.S. Food and Drug Administration has failed to tighten up and improve its safety oversight of the foreign drugs entering the country, suggesting a gaping hole in the agency's security...To view the full article, register now.
Already a subscriber? Click here to view full article